Syzygenic, your scenario is interesting and maybe the BCSC opens up some sales of shares that increase volume. But again, that is a "so what" issue. I have been with this company close to 5 years and my take is that until they have some significant info to show they are making progress in the development of the cell lines i.e. getting them produced and filing the IND, this stock is dead in the water at best. That is how things have worked for the past 3-4 years. I don't see any of that changing.
Market Data 
Markets 
AI
